新型碳青霉烯类抗生素LJC 10,627的肾脱氢肽酶-I稳定性
Renal dehydropeptidase-I stability of LJC 10,627, a new carbapenem antibiotic.
作者信息
Hikida M, Kawashima K, Nishiki K, Furukawa Y, Nishizawa K, Saito I, Kuwao S
机构信息
Biological Research Laboratories, Lederle Ltd., Saitama, Japan.
出版信息
Antimicrob Agents Chemother. 1992 Feb;36(2):481-3. doi: 10.1128/AAC.36.2.481.
Abstract
LJC 10,627 is a new parenteral carbapenem antibiotic. LJC 10,627 stability against human renal dehydropeptidase-I was compared with that of imipenem. Hydrolysis of this compound was not detectable by spectrophotometrical assay. Even after a 2-h incubation of antibiotics with this enzyme at 30 degrees C, the concentration of LJC 10,627 remained at 92.3% of the initial concentration, whereas imipenem completely disappeared. Thus, it was found that this compound was highly stable against human renal dehydropeptidase-I. Furthermore, LJC 10,627 had a low affinity for this enzyme, as indicated by the high Ki value (0.38 mM).
摘要
LJC 10,627是一种新型的肠外碳青霉烯类抗生素。将LJC 10,627对人肾脱氢肽酶-I的稳定性与亚胺培南进行了比较。通过分光光度法检测不到该化合物的水解情况。即使在30℃下将抗生素与该酶孵育2小时后，LJC 10,627的浓度仍保持在初始浓度的92.3%，而亚胺培南则完全消失。因此，发现该化合物对人肾脱氢肽酶-I具有高度稳定性。此外，如高Ki值（0.38 mM）所示，LJC 10,627对该酶的亲和力较低。
相似文献
1
Renal dehydropeptidase-I stability of LJC 10,627, a new carbapenem antibiotic.
Antimicrob Agents Chemother. 1992 Feb;36(2):481-3. doi: 10.1128/AAC.36.2.481.
2
Inactivation of new carbapenem antibiotics by dehydropeptidase-I from porcine and human renal cortex.
J Antimicrob Chemother. 1992 Aug;30(2):129-34. doi: 10.1093/jac/30.2.129.
3
In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I.
Antimicrob Agents Chemother. 1990 Jun;34(6):994-1000. doi: 10.1128/AAC.34.6.994.
4
In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
Antimicrob Agents Chemother. 1999 Aug;43(8):2010-6. doi: 10.1128/AAC.43.8.2010.
5
Cilastatin-sensitive dehydropeptidase I enzymes from three sources all catalyze carbapenem hydrolysis and conversion of leukotriene D4 to leukotriene E4.
Arch Biochem Biophys. 1987 Jul;256(1):253-9. doi: 10.1016/0003-9861(87)90443-7.
6
Kinetic analysis of dehydropeptidase-I and comparative in vitro and in vivo stabilities of PS-5 derivatives modified at the C-3 side chain.
Chem Pharm Bull (Tokyo). 1991 Feb;39(2):341-8. doi: 10.1248/cpb.39.341.
7
Susceptibility of naturally occurring carbapenem antibiotics to renal dehydropeptidase-I. An easy assay using a plate technique based on a novel chromogenic beta-lactamase substrate.
J Antibiot (Tokyo). 1983 Jul;36(7):876-9. doi: 10.7164/antibiotics.36.876.
8
Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties.
Antimicrob Agents Chemother. 1999 Dec;43(12):2904-9. doi: 10.1128/AAC.43.12.2904.
9
In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity.
Antimicrob Agents Chemother. 1993 Dec;37(12):2756-9. doi: 10.1128/AAC.37.12.2756.
10
Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase.
Antimicrob Agents Chemother. 1982 Jul;22(1):62-70. doi: 10.1128/AAC.22.1.62.
引用本文的文献
1
PK/PD analysis of biapenem in patients undergoing continuous hemodiafiltration.
J Pharm Health Care Sci. 2015 Nov 14;1:31. doi: 10.1186/s40780-015-0031-6. eCollection 2015.
2
In vitro activity of tebipenem, a new oral carbapenem antibiotic, against penicillin-nonsusceptible Streptococcus pneumoniae.
Antimicrob Agents Chemother. 2005 Mar;49(3):889-94. doi: 10.1128/AAC.49.3.889-894.2005.
3
Biapenem.
Drugs. 2002;62(15):2221-34; discussion 2235. doi: 10.2165/00003495-200262150-00005.
4
Emerging strategies in infectious diseases: new carbapenem and trinem antibacterial agents.
Drugs. 2001;61(5):553-64. doi: 10.2165/00003495-200161050-00001.
5
Pharmacokinetics and safety of a new parenteral carbapenem antibiotic, biapenem (L-627), in elderly subjects.
Antimicrob Agents Chemother. 1998 Jun;42(6):1433-6. doi: 10.1128/AAC.42.6.1433.
6
Low neurotoxicity of LJC 10,627, a novel 1 beta-methyl carbapenem antibiotic: inhibition of gamma-aminobutyric acidA, benzodiazepine, and glycine receptor binding in relation to lack of central nervous system toxicity in rats.
Antimicrob Agents Chemother. 1993 Feb;37(2):199-202. doi: 10.1128/AAC.37.2.199.
7
Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.
Eur J Clin Microbiol Infect Dis. 1993 May;12(5):384-91. doi: 10.1007/BF01964439.
8
In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem.
Antimicrob Agents Chemother. 1995 May;39(5):1030-7. doi: 10.1128/AAC.39.5.1030.
9
Interactions of biapenem with active-site serine and metallo-beta-lactamases.
Antimicrob Agents Chemother. 1995 Jun;39(6):1300-5. doi: 10.1128/AAC.39.6.1300.
本文引用的文献
1
Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase.
Antimicrob Agents Chemother. 1982 Jul;22(1):62-70. doi: 10.1128/AAC.22.1.62.
2
In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria.
J Antimicrob Chemother. 1983 Dec;12 Suppl D:53-64. doi: 10.1093/jac/12.suppl_d.53.
3
A spectrophotometric assay of beta-lactamase action on penicillins.
Biochem J. 1974 Jun;139(3):789-90. doi: 10.1042/bj1390789.
4
Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin.
Am J Med. 1985 Jun 7;78(6A):3-21. doi: 10.1016/0002-9343(85)90097-x.
5
In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem.
Antimicrob Agents Chemother. 1986 Dec;30(6):828-34. doi: 10.1128/AAC.30.6.828.
6
In vitro and pharmacokinetic properties of the carbapenems.
Antimicrob Agents Chemother. 1986 Sep;30(3):343-9. doi: 10.1128/AAC.30.3.343.
7
In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338.
Antimicrob Agents Chemother. 1989 Jul;33(7):1009-18. doi: 10.1128/AAC.33.7.1009.
8
In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I.
Antimicrob Agents Chemother. 1990 Jun;34(6):994-1000. doi: 10.1128/AAC.34.6.994.
Zotero 插件